Structural differences determine the relative selectivity of nicotinic compounds for native α4β2*-, α6β2*-, α3β4*- and α7-nicotine acetylcholine receptors

Varenicline:  An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930 · see citing works

Brain nicotinic acetylcholine receptors: native subtypes and their relevance

Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882 · see citing works

A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.

Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880 · see citing works

Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors

Mihalak, K. B., Carroll, F. I., & Luetje, C. W. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025130 · Cited by 558 · see citing works

Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

Rollema, H., Chambers, L. K., Coe, J. W., Glowa, J., Hurst, R. S., Lebel, L. A., Lu, Y., Mansbach, R. S., Mather, R. J., Rovetti, C. C., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.016 · Cited by 533 · see citing works

Subunit Composition of Functional Nicotinic Receptors in Dopaminergic Neurons Investigated with Knock-Out Mice

Champtiaux, N., Gotti, C., Cordero‐Erausquin, M., David, D. J. P., Przybylski, C., Léna, C., Clementi, F., Moretti, M., Rossi, F., Novère, N. G. L., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07820.2003 · Cited by 505 · see citing works

Subunit Composition and Pharmacology of Two Classes of Striatal Presynaptic Nicotinic Acetylcholine Receptors Mediating Dopamine Release in Mice

Salminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. C., & Grady, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1526 · Cited by 401 · see citing works

Distribution and Pharmacology of α6-Containing Nicotinic Acetylcholine Receptors Analyzed with Mutant Mice

Champtiaux, N., Han, Z., Bessis, A., Rossi, F., Zoli, M., Marubio, L. M., McIntosh, J. M., & Changeux, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-04-01208.2002 · Cited by 345 · see citing works

Crucial role of α4 and α6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration

Pons, S., Fattore, L., Cossu, G., Tolu, S., Porcu, E., McIntosh, J. M., Changeux, J. P., Maskos, U., & Fratta, W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3918-08.2008 · Cited by 312 · see citing works

Hierarchical Control of Dopamine Neuron-Firing Patterns by Nicotinic Receptors

Mameli-Engvall, M., Evrard, A., Pons, S., Maskos, U., Svensson, T. H., Changeux, J.-P., & Faure, P. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.007 · Cited by 296 · see citing works

Chronic Nicotine Cell Specifically Upregulates Functional α4* Nicotinic Receptors: Basis for Both Tolerance in Midbrain and Enhanced Long-Term Potentiation in Perforant Path

Nashmi, R., Xiao, C., Deshpande, P., McKinney, S., Grady, S. R., Whiteaker, P., Huang, Q., McClure-Begley, T., Lindstrom, J. M., Labarca, C., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2199-07.2007 · Cited by 274 · see citing works

Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.

Marks, M. J., Stitzel, J. A., Romm, E., Wehner, J. M., & Collins, A. C. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10395-7 · Cited by 267 · see citing works

α6-Containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens

Exley, R., Clements, M. A., Hartung, H., McIntosh, J. M., & Cragg, S. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301617 · Cited by 242 · see citing works

In vivo activation of midbrain dopamine neurons via sensitized, high-affinity α6 nicotinic acetylcholine receptors

Drenan, R. M., Grady, S. R., Whiteaker, P., McClure-Begley, T., McKinney, S., Miwa, J. M., Bupp, S., Heintz, N., McIntosh, J. M., Bencherif, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.09.009 · Cited by 197 · see citing works

Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery

Lester, H. A., Xiao, C., Srinivasan, R., Son, C. D., Miwa, J., Pantoja, R., Banghart, M. R., Dougherty, D. A., Goate, A. M., & Wang, J. C. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9090-7 · Cited by 163 · cited 3× · see citing works

125I-α-Conotoxin MII Identifies a Novel Nicotinic Acetylcholine Receptor Population in Mouse Brain

Whiteaker, P., McIntosh, J. M., Luo, S., Collins, A. C., & Marks, M. J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26500-7 · Cited by 160 · see citing works

125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain.

Whiteaker, P., McIntosh, J. M., Luo, S., Collins, A. C., & Marks, M. J. (2000) · PubMed · Cited by 158 · see citing works

Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum

Grady, S. R., Meinerz, N. M., Cao, J., Reynolds, A. M., Picciotto, M. R., Changeux, J., McIntosh, J. M., Marks, M. J., & Collins, A. C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00019.x · Cited by 156 · see citing works

Translational research in medication development for nicotine dependence

Lerman, C. E., LeSage, M. G., Perkins, K. A., O’Malley, S. S., Siegel, S. J., Benowitz, N. L., & Corrigall, W. A. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2361 · Cited by 149 · see citing works

Pharmacology of α-Conotoxin MII-Sensitive Subtypes of Nicotinic Acetylcholine Receptors Isolated by Breeding of Null Mutant Mice

Salminen, O., Drapeau, J. A., McIntosh, J. M., Collins, A. C., Marks, M. J., & Grady, S. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.031492 · Cited by 149 · see citing works

Involvement of the α3 Subunit in Central Nicotinic Binding Populations

Whiteaker, P., Peterson, C. G., Xu, W., McIntosh, J. M., Paylor, R. E., Beaudet, A. L., Collins, A. C., & Marks, M. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02522.2002 · Cited by 145 · see citing works

RJR-2403: a nicotinic agonist with CNS selectivity I. In vitro characterization.

Bencherif, M., Lovette, M. E., Fowler, K., Arrington, S. R., Reeves, L., Caldwell, W. S., & Lippiello, P. M. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21302-7 · Cited by 141 · see citing works

Differential Agonist Inhibition Identifies Multiple Epibatidine Binding Sites in Mouse Brain

Marks, M. J., Smith, K. W., & Collins, A. C. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37384-7 · Cited by 140 · see citing works

Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit.

Marks, M. J., Whiteaker, P., Calcaterra, J., Stitzel, J. A., Bullock, A. E., Grady, S. R., Picciotto, M. R., Changeux, J., & Collins, A. C. (1999) · PubMed · Cited by 126 · see citing works

Overview of the pharmacogenomics of cigarette smoking

Ho, M., & Tyndale, R. F. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500436 · Cited by 114 · see citing works

Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes.

Marks, M. J., Farnham, D. A., Grady, S. R., & Collins, A. C. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10175-4 · Cited by 112 · see citing works

Long-Term Nicotine Treatment Decreases Striatal α6* Nicotinic Acetylcholine Receptor Sites and Function in Mice

Lai, A., Parameswaran, N., Khwaja, M., Whiteaker, P., Lindstrom, J. M., Fan, H., McIntosh, J. M., Grady, S. R., & Quik, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006429 · Cited by 112 · see citing works

Chronic Nicotine Differentially Regulates α6- and β3-Containing Nicotinic Cholinergic Receptors in Rat Brain

Perry, D. C., Mao, D., Gold, A. B., McIntosh, J. M., Pezzullo, J. C., & Kellar, K. J. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121228 · Cited by 106 · see citing works

Identification of a novel nicotinic binding site in mouse brain using [125I]‐epibatidine

Whiteaker, P., Jimenez, M., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703616 · Cited by 105 · see citing works

Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette

Brody, A. L., Mandelkern, M. A., Costello, M. R., Abrams, A. L., Scheibal, D., Farahi, J. B., London, E. D., Olmstead, R. E., Rose, J. E., & Mukhin, A. G. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570800922x · Cited by 101 · see citing works

The neuronal nicotinic receptor subunit genes (CHRNA6 and CHRNB3) are associated with subjective responses to tobacco

Zeiger, J. S., Haberstick, B. C., Schlaepfer, I. R., Collins, A. C., Corley, R. P., Crowley, T. J., Hewitt, J. K., Hopfer, C. J., Lessem, J. M., McQueen, M. B., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm344 · Cited by 99 · see citing works

Genetic Association of the CHRNA6 and CHRNB3 Genes with Tobacco Dependence in a Nationally Representative Sample

Hoft, N. R., Corley, R. P., McQueen, M. B., Schlaepfer, I. R., Huizinga, D. H., & Ehringer, M. A. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.122 · Cited by 97 · see citing works

Influence of Neuronal Nicotinic Receptors over Nicotine Addiction and Withdrawal

De Biasi, M., & Salas, R. (2008) · Experimental Biology and Medicine · doi:10.3181/0712-mr-355 · Cited by 95 · see citing works

Differential Declines in Striatal Nicotinic Receptor Subtype Function after Nigrostriatal Damage in Mice

Quik, M., Sum, J., Whiteaker, P., McCallum, S. E., Marks, M. J., Musachio, J. L., McIntosh, J. M., Collins, A. C., & Grady, S. R. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1169 · Cited by 83 · see citing works

Extending the analysis of nicotinic receptor antagonists with the study of α6 nicotinic receptor subunit chimeras

Papke, R. L., Dwoskin, L. P., Crooks, P. A., Zheng, G., Zhang, Z., McIntosh, J. M., & Stokes, C. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.03.010 · Cited by 79 · see citing works

Two Pharmacologically Distinct Components of Nicotinic Receptor-Mediated Rubidium Efflux in Mouse Brain Require the β2 Subunit

Marks, M. J., Whiteaker, P., Calcaterra, J., Stitzel, J. A., Bullock, A. E., Grady, S. R., Picciotto, M. R., Changeux, J.-P., & Collins, A. C. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38240-0 · Cited by 79 · see citing works

Long-term nicotine treatment differentially regulates striatal α6α4β2* and α6(nonα4)β2* nAChR expression and function

Perez, X. A., Bordia, T., McIntosh, J. M., Grady, S. R., & Quik, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048843 · Cited by 77 · see citing works

β3 Subunits Promote Expression and Nicotine-Induced Up-Regulation of Human Nicotinic α6* Nicotinic Acetylcholine Receptors Expressed in Transfected Cell Lines

Tumkosit, P., Kuryatov, A., Luo, J., & Lindstrom, J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027326 · Cited by 73 · see citing works

Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation

McCallum, S. E., Collins, A. C., Paylor, R. E., & Marks, M. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0076-6 · Cited by 72 · see citing works

Differential Modulation by Nicotine of Substantia Nigra Versus Ventral Tegmental Area Dopamine Neurons

Keath, J. R., Iacoviello, M. P., Barrett, L. E., Mansvelder, H. D., & McGehee, D. S. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00760.2007 · Cited by 66 · see citing works

Nicotinic agonists differ in activation and desensitization of 86Rb+ efflux from mouse thalamic synaptosomes.

Marks, M. J., Robinson, S. F., & Collins, A. C. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13086-3 · Cited by 65 · see citing works

The Activation and Inhibition of Human Nicotinic Acetylcholine Receptor by RJR‐2403 Indicate a Selectivity for the α4β2 Receptor Subtype

Papke, R. L., Webster, J. C., Lippiello, P. M., Bencherif, M., & Francis, M. M. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750204.x · Cited by 63 · see citing works

The subunit composition and pharmacology of α-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay

Salminen, O., Whiteaker, P., Grady, S. R., Collins, A. C., McIntosh, J. M., & Marks, M. J. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.011 · Cited by 63 · see citing works

Deletion of the α7, β2, or β4 Nicotinic Receptor Subunit Genes Identifies Highly Expressed Subtypes with Relatively Low Affinity for [3H]Epibatidine

Marks, M. J., Whiteaker, P., & Collins, A. C. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025338 · Cited by 53 · see citing works

3D QSAR Analyses-Guided Rational Design of Novel Ligands for the (α4)2(β2)3 Nicotinic Acetylcholine Receptor

Gohlke, H., Schwarz, S., Gündisch, D., Tilotta, M. C., Weber, A., Wegge, T., & SEITZ, G. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020859m · Cited by 45 · see citing works

In vitro screening strategies for nicotinic receptor ligands

Dunlop, J., Roncarati, R., Jow, B., Bothmann, H., Lock, T., Kowal, D. M., Bowlby, M. R., & Terstappen, G. C. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.006 · Cited by 44 · see citing works

Gene targeting demonstrates that α4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine

Marks, M. J., Meinerz, N. M., Drago, J., & Collins, A. C. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.021 · Cited by 42 · see citing works

Nicotine responses in hypersensitive and knockout α4 mice account for tolerance to both hypothermia and locomotor suppression in wild-type mice

Tapper, A. R., McKinney, S. L., Marks, M. J., & Lester, H. A. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00063.2007 · Cited by 40 · see citing works

Synthesis of 2-(Pyridin-3-yl)-1-azabicyclo[3.2.2]nonane, 2-(Pyridin-3-yl)-1-azabicyclo[2.2.2]octane, and 2-(Pyridin-3-yl)-1-azabicyclo[3.2.1]octane, a Class of Potent Nicotinic Acetylcholine Receptor–Ligands

Bhatti, B. S., Strachan, J., Breining, S. R., Miller, C. H., Tahiri, P., Crooks, P. A., Deo, N., Day, C. S., & Caldwell, W. S. (2008) · The Journal of Organic Chemistry · doi:10.1021/jo800028q · Cited by 18 · see citing works

A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence

Litten, R. Z., Ryan, M. L., Fertig, J. B., Falk, D. E., Johnson, B., Dunn, K. E., Green, A. I., Pettinati, H. M., Ciraulo, D. A., Sarid-Segal, O., et al. (2013) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31829623f4 · Cited by 287 · see citing works

α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson’s Disease

Quik, M., & Wonnacott, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003269 · Cited by 194 · see citing works

Nicotine Withdrawal

McLaughlin, I., Dani, J. A., & De Biasi, M. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/978-3-319-13482-6_4 · Cited by 173 · see citing works

Synaptic-like axo-axonal transmission from striatal cholinergic interneurons onto dopaminergic fibers

Kramer, P. F., Brill-Weil, S. G., Cummins, A. C., Zhang, R., Camacho-Hernandez, G. A., Newman, A. H., Eldridge, M. A. G., Averbeck, B. B., & Khaliq, Z. M. (2022) · Neuron · doi:10.1016/j.neuron.2022.07.011 · Cited by 104 · see citing works

Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders

Quik, M., Perez, X. A., & Grady, S. R. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.001 · Cited by 94 · see citing works

Functional Nicotinic Acetylcholine Receptors Containing α6 Subunits Are on GABAergic Neuronal Boutons Adherent to Ventral Tegmental Area Dopamine Neurons

Yang, K., Buhlman, L. M., Khan, G. M., Nichols, R. A., Jin, G.-Z., McIntosh, J. M., Whiteaker, P., Lukas, R. J., & Wu, J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3003-10.2011 · Cited by 85 · see citing works

Nicotine aversion is mediated by GABAergic interpeduncular nucleus inputs to laterodorsal tegmentum

Wolfman, S. L., Gill, D. F., Bogdanic, F., Long, K., Al-Hasani, R., McCall, J. G., Bruchas, M. R., & McGehee, D. S. (2018) · Nature Communications · doi:10.1038/s41467-018-04654-2 · Cited by 81 · see citing works

Varenicline and Cytisine Diminish the Dysphoric-Like State Associated with Spontaneous Nicotine Withdrawal in Rats

Igari, M., Alexander, J. C., Ji, Y. R., Qi, X., Papke, R. L., & Bruijnzeel, A. W. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.216 · Cited by 75 · see citing works

Varenicline Is a Potent Partial Agonist at α6β2* Nicotinic Acetylcholine Receptors in Rat and Monkey Striatum

Bordia, T., Hrachova, M., Chin, M., McIntosh, J. M., & Quik, M. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194852 · Cited by 70 · see citing works

Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens

Feduccia, A. A., Simms, J. A., Mill, D., Yi, H. Y., & Bartlett, S. E. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12690 · Cited by 69 · see citing works

How Menthol Alters Tobacco-Smoking Behavior: A Biological Perspective.

Wickham, R. J. (2015) · PubMed Central · Cited by 65 · see citing works

Addiction‐related neuroadaptations following chronic nicotine exposure

Wills, L., & Kenny, P. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15356 · Cited by 61 · see citing works

Moderators of Varenicline Treatment Effects in a Double-Blind, Placebo-Controlled Trial for Alcohol Dependence

Falk, D. E., Castle, I. P., Ryan, M., Fertig, J. B., & Litten, R. Z. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000133 · Cited by 59 · see citing works

Low concentrations of nicotine differentially desensitize nicotinic acetylcholine receptors that include α5 or α6 subunits and that mediate synaptosomal neurotransmitter release

Grady, S. R., Wageman, C. R., Patzlaff, N. E., & Marks, M. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.026 · Cited by 56 · see citing works

PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans

Hillmer, A. T., Li, S., Zheng, M., Scheunemann, M., Lin, S.-F., Nabulsi, N., Holden, D., Pracitto, R., Labaree, D. C., Ropchan, J. R., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3621-8 · Cited by 54 · see citing works

Insights into the Neurobiology of the Nicotinic Cholinergic System and Nicotine Addiction from Mice Expressing Nicotinic Receptors Harboring Gain-of-Function Mutations

Drenan, R. M., & Lester, H. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004671 · Cited by 51 · see citing works

Nicotinic Receptor Agonists Reduce l-DOPA–Induced Dyskinesias in a Monkey Model of Parkinson's Disease

Zhang, D., Mallela, A., Sohn, D., Carroll, F. I., Bencherif, M., Letchworth, S. R., & Quik, M. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.207639 · Cited by 49 · see citing works

Nicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behavior

Cohen, B. N., Mackey, E. D. W., Grady, S. R., McKinney, S. L., Patzlaff, N. E., Wageman, C. R., McIntosh, J. M., Marks, M. J., Lester, H. A., & Drenan, R. M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.047 · Cited by 47 · see citing works

Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation

Brunzell, D. H., McIntosh, J. M., & Papke, R. L. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12421 · Cited by 40 · see citing works

Low Dose Nicotine and Antagonism of β2 Subunit Containing Nicotinic Acetylcholine Receptors Have Similar Effects on Affective Behavior in Mice

Anderson, S. M., & Brunzell, D. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048665 · Cited by 40 · see citing works

New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice

Bağdaş, D., Alkhlaif, Y., Jackson, A. B., Carroll, F. I., Ditre, J. W., & Damaj, M. I. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.025 · Cited by 40 · see citing works

Stimulation of α7 nicotinic acetylcholine receptor by AR-R17779 suppresses atherosclerosis and aortic aneurysm formation in apolipoprotein E-deficient mice

Hashimoto, T., Ichiki, T., Watanabe, A., Hurt‐Camejo, E., Michaëlsson, E., Ikeda, J., Inoue, E., Matsuura, H., Tokunou, T., Kitamoto, S., et al. (2014) · Vascular Pharmacology · doi:10.1016/j.vph.2014.03.006 · Cited by 39 · see citing works

Neuronal Nicotinic Acetylcholine Receptor Modulators Reduce Sugar Intake

Shariff, M. R., Quik, M., Holgate, J. Y., Morgan, M., Patkar, O. L., Tam, V., Belmer, A., & Bartlett, S. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150270 · Cited by 40 · see citing works

Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse

Skike, C. E. V., Maggio, S. E., Reynolds, A. R., Casey, E. M., Bardo, M. T., Dwoskin, L. P., Prendergast, M., & Nixon, K. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.004 · Cited by 39 · see citing works

Characterizing functional α6β2 nicotinic acetylcholine receptors in vitro: Mutant β2 subunits improve membrane expression, and fluorescent proteins reveal responsive cells

Xiao, C., Srinivasan, R., Drenan, R. M., Mackey, E. D. W., McIntosh, J. M., & Lester, H. A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.005 · Cited by 37 · see citing works

The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data

Rollema, H., & Hurst, R. S. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4921-9 · Cited by 38 · see citing works

Nicotine and ethanol cooperate to enhance ventral tegmental area AMPA receptor function via α6-containing nicotinic receptors

Engle, S. E., McIntosh, J. M., & Drenan, R. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.014 · Cited by 33 · see citing works

Cell‐Derived Vesicles for Single‐Molecule Imaging of Membrane Proteins

Moonschi, F. H., Effinger, A. K., Zhang, X., Martin, W. E., Fox-Loe, A. M., Heidary, D. K., DeRouchey, J. E., & Richards, C. I. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201408707 · Cited by 32 · see citing works

Preclinical Evidence That Activation of Mesolimbic Alpha 6 Subunit Containing Nicotinic Acetylcholine Receptors Supports Nicotine Addiction Phenotype

Brunzell, D. H. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts089 · Cited by 32 · see citing works

α6-Containing nicotinic acetylcholine receptors in midbrain dopamine neurons are poised to govern dopamine-mediated behaviors and synaptic plasticity

Berry, J. N., Engle, S. E., McIntosh, J. M., & Drenan, R. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.052 · Cited by 30 · see citing works

Varenicline enhances dopamine release facilitation more than nicotine after long‐term nicotine treatment and withdrawal

Perez, X. A., Khroyan, T. V., McIntosh, J. M., & Quik, M. (2014) · Pharmacology Research & Perspectives · doi:10.1002/prp2.105 · Cited by 29 · see citing works

Structure–Activity Relationship Studies of Sulfonylpiperazine Analogues as Novel Negative Allosteric Modulators of Human Neuronal Nicotinic Receptors

Henderson, B. J., Carper, D. J., González-Cestari, T. F., Yi, B., Mahasenan, K. V., Pavlovicz, R. E., Dalefield, M. L., Coleman, R. S., Li, C., & McKay, D. B. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201294r · Cited by 29 · see citing works

Endogenous Cholinergic Inputs and Local Circuit Mechanisms Govern the Phasic Mesolimbic Dopamine Response to Nicotine

Graupner, M., Maex, R., & Gutkin, B. S. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003183 · Cited by 26 · see citing works

Effects of Chronic Varenicline Treatment on Nicotine, Cocaine, and Concurrent Nicotine+Cocaine Self-Administration

Mello, N. K., Fivel, P. A., Kohut, S. J., & Carroll, F. I. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.325 · Cited by 26 · see citing works

The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice

de Moura, F. B., & McMahon, L. R. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4514-4 · Cited by 28 · see citing works

Unichiral 2-(2′-Pyrrolidinyl)-1,4-benzodioxanes: the 2 R ,2′ S Diastereomer of the N -Methyl-7-hydroxy Analogue Is a Potent α4β2- and α6β2-Nicotinic Acetylcholine Receptor Partial Agonist

Bolchi, C., Gotti, C., Binda, M., Fumagalli, L., Pucci, L., Pistillo, F., Vistoli, G., Valoti, E., & Pallavicini, M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200937t · Cited by 27 · see citing works

Insights Into Nicotinic Receptor Signaling in Nicotine Addiction: Implications for Prevention and Treatment

Liu, W., & Li, M. D. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170801103009 · Cited by 27 · see citing works

Blocking α4β2 and α7 nicotinic acetylcholine receptors inhibits the reinstatement of morphine-induced CPP by drug priming in mice

Feng, B., Xing, J.-H., Jia, D., Liu, S., Guo, H.-J., Li, X., He, X., & Zhao, M. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.040 · Cited by 26 · see citing works

Crucial roles of the CHRNB3–CHRNA6 gene cluster on chromosome 8 in nicotine dependence: update and subjects for future research

Wen, L., Yang, Z., Cui, W., & Li, M. D. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.103 · Cited by 26 · see citing works

Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes

Arias, H. R., Feuerbach, D., Targowska‐Duda, K. M., Kaczor, A. A., Poso, A., & Jóźwiak, K. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.11.003 · Cited by 25 · see citing works

Nicotinic acetylcholine receptors: Key targets for attenuating neurodegenerative diseases

Bye, L. J., Finol‐Urdaneta, R. K., Tae, H., & Adams, D. J. (2023) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2023.106387 · Cited by 28 · see citing works

Varenicline Reduces Context-Induced Relapse to Alcohol-Seeking through Actions in the Nucleus Accumbens

Lacroix, F., Pettorelli, A., Maddux, J.-M. N., Heidari-Jam, A., & Chaudhri, N. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.254 · Cited by 24 · see citing works

The nicotine‐mediated decline in l ‐dopa‐induced dyskinesias is associated with a decrease in striatal dopamine release

Bordia, T., McIntosh, J. M., & Quik, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12179 · Cited by 23 · see citing works

Chronic treatment with varenicline changes expression of four nAChR binding sites in mice

Marks, M. J., O’Neill, H. C., Wynalda, K., Ortiz, N. C., Simmons, E. E., Short, C. A., Butt, C. M., McIntosh, J. M., & Grady, S. R. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.019 · Cited by 23 · see citing works

Varenicline Blocks 2*-nAChR-Mediated Response and Activates 4*-nAChR-Mediated Responses in Mice In Vivo

Ortiz, N. C., O'Neill, H. C., Marks, M. J., & Grady, S. R. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr284 · Cited by 22 · see citing works

Understanding the Role α7 Nicotinic Receptors Play in Dopamine Efflux in Nucleus Accumbens

Maex, R., Grinevich, V. P., Grinevich, V. P., Budygin, E. A., Bencherif, M., & Gutkin, B. S. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500126t · Cited by 22 · see citing works

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices

Engle, S. E., Broderick, H. J., & Drenan, R. M. (2012) · Journal of Visualized Experiments · doi:10.3791/50034 · Cited by 24 · see citing works

Therapeutic challenges for concurrent ethanol and nicotine consumption: naltrexone and varenicline fail to alter simultaneous ethanol and nicotine intake by female alcohol-preferring (P) rats

Waeiss, R. A., Knight, C. P., Hauser, S. R., Pratt, L. A., McBride, W. J., & Rodd, Z. A. (2019) · Psychopharmacology · doi:10.1007/s00213-019-5174-y · Cited by 22 · see citing works

Oral exposure to aluminum leads to reduced nicotinic acetylcholine receptor gene expression, severe neurodegeneration and impaired hippocampus dependent learning in mice

Farhat, S. M., Mahboob, A., & Ahmed, T. (2019) · Drug and Chemical Toxicology · doi:10.1080/01480545.2019.1587452 · Cited by 20 · see citing works

Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids

Cunningham, C. S., & McMahon, L. R. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3037-5 · Cited by 19 · see citing works

Neonicotinic analogues: Selective antagonists for α4β2 nicotinic acetylcholine receptors

Faundez‐Parraguez, M., Farias-Rabelo, N., González-Gutiérrez, J. P., Etcheverry-Berríos, Á., Alzate‐Morales, J. H., Adasme‐Carreño, F., Varas, R., Bermúdez, I., & Iturriaga‐Vásquez, P. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.03.024 · Cited by 19 · see citing works

Differentiating the primary reinforcing and reinforcement-enhancing effects of varenicline

Schassburger, R. L., Levin, M. E., Weaver, M. T., Palmatier, M. I., Caggiula, A. R., Donny, E. C., & Sved, A. F. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3732-x · Cited by 18 · see citing works

Discriminative stimulus and hypothermic effects of some derivatives of the nAChR agonist epibatidine in mice

Rodriguez, J. S., Cunningham, C. S., de Moura, F. B., Ondachi, P. W., Carroll, F. I., & McMahon, L. R. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3589-z · Cited by 15 · see citing works

Effectiveness of Nicotinic Agonists as Desensitizers at Presynaptic 4 2- and 4 5 2-Nicotinic Acetylcholine Receptors

Wageman, C. R., Marks, M. J., & Grady, S. R. (2013) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntt146 · Cited by 16 · see citing works

A behavioral economic analysis of the value-enhancing effects of nicotine and varenicline and the role of nicotinic acetylcholine receptors in male and female rats

Barrett, S. T., Geary, T. N., Steiner, A. N., & Bevins, R. A. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000404 · Cited by 16 · see citing works

Structure–Activity Studies of 7-Heteroaryl-3-azabicyclo[3.3.1]non-6-enes: A Novel Class of Highly Potent Nicotinic Receptor Ligands

Breining, S. R., Melvin, M. S., Bhatti, B. S., Byrd, G. D., Kiser, M. N., Hepler, C. D., Hooker, D. N., Zhang, J., Reynolds, L. A., Benson, L. R., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3011299 · Cited by 15 · see citing works

Physical and virtual screening methods for marine toxins and drug discovery targeting nicotinic acetylcholine receptors

Molgó, J., Aráoz, R., Benoit, É., & Iorga, B. I. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.822365 · Cited by 14 · see citing works

Secondary Ammonium Agonists Make Dual Cation-π Interactions in α4β2 Nicotinic Receptors

Post, M. R., Tender, G. S., Lester, H. A., & Dougherty, D. A. (2017) · eNeuro · doi:10.1523/eneuro.0032-17.2017 · Cited by 14 · see citing works

Defining the Putative Inhibitory Site for a Selective Negative Allosteric Modulator of Human α4β2 Neuronal Nicotinic Receptors

Henderson, B. J., González-Cestari, T. F., Yi, B., Pavlovicz, R. E., Boyd, R. T., Li, C., Bergmeier, S. C., & McKay, D. B. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300035f · Cited by 12 · see citing works

The nicotinic receptor drug sazetidine-A reduces alcohol consumption in mice without affecting concurrent nicotine consumption

Touchette, J. C., Maertens, J. J., Mason, M. M., O’Rourke, K. Y., & Lee, A. M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.019 · Cited by 13 · see citing works

The interpeduncular nucleus blunts the rewarding effect of nicotine

Jehl, J., Ciscato, M., Vicq, É., Guyon, N., de la Bâtie, G. D., Mondoloni, S., Frangieh, J., Mohayyaei, M., Nguyen, C., Pons, S., et al. (2023) · Neuron · doi:10.1016/j.neuron.2025.03.035 · Cited by 12 · see citing works

Altered nicotine reward-associated behavior following α4 nAChR subunit deletion in ventral midbrain

Peng, C., Engle, S. E., Yan, Y., Weera, M. M., Berry, J. N., Arvin, M. C., Zhao, G., McIntosh, J. M., Chester, J. A., & Drenan, R. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182142 · Cited by 12 · see citing works

Mammalian Cell-derived Vesicles for the Isolation of Organelle Specific Transmembrane Proteins to Conduct Single Molecule Studies

Moonschi, F. H., Fox-Loe, A. M., Fu, X., & Richards, C. I. (2018) · BIO-PROTOCOL · doi:10.21769/bioprotoc.2825 · Cited by 12 · see citing works

Role of α4- and α6-containing nicotinic receptors in the acquisition and maintenance of nicotine self-administration

Madsen, H. B., Koghar, H. S., Pooters, T., Massalas, J. S., Drago, J., & Lawrence, A. J. (2014) · Addiction Biology · doi:10.1111/adb.12148 · Cited by 13 · see citing works

Varenicline, the clinically effective smoking cessation agent, restores probabilistic response reversal performance during withdrawal from nicotine

Jackson, A. E., Silk, S., Buhidma, Y., & Shoaib, M. C. (2016) · Addiction Biology · doi:10.1111/adb.12423 · Cited by 11 · see citing works

A novel α‐conotoxin MII‐sensitive nicotinic acetylcholine receptor modulates [3H]‐GABA release in the superficial layers of the mouse superior colliculus

McClure‐Begley, T. D., Wageman, C. R., Grady, S. R., Marks, M. J., McIntosh, J. M., Collins, A. C., & Whiteaker, P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07759.x · Cited by 11 · see citing works

Recent advances in gene manipulation and nicotinic acetylcholine receptor biology

Tammimäki, A., Horton, W. J., & Stitzel, J. A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.014 · Cited by 10 · see citing works

Suppression of abdominal aortic aneurysm formation by AR-R17779, an agonist for the α7 nicotinic acetylcholine receptor

Watanabe, A., Ichiki, T., Kojima, H., Takahara, Y., Hurt‐Camejo, E., Michaëlsson, E., Sankoda, C., Ikeda, J., Inoue, E., Tokunou, T., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.11.006 · Cited by 10 · see citing works

Differential antagonism and tolerance/cross-tolerance among nicotinic acetylcholine receptor agonists

de Moura, F. B., & McMahon, L. R. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000233 · Cited by 8 · see citing works

Baroreflex deficiency aggravates atherosclerosis via α7 nicotinic acetylcholine receptor in mice

Chen, L., Liu, D., Zhang, X., Zhang, E.-H., Liu, C., Su, D., & Cai, G. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.08.008 · Cited by 9 · see citing works

The role of nicotinic receptors in alcohol consumption

Kamens, H. M., Flarend, G., & Horton, W. J. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106705 · Cited by 8 · see citing works

Heterologous expression and nonsense suppression provide insights into agonist behavior at α6β2 nicotinic acetylcholine receptors

Post, M. R., Limapichat, W., Lester, H. A., & Dougherty, D. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.04.009 · Cited by 8 · see citing works

TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors

Wall, T. R., Henderson, B. J., Voren, G., Wageman, C. R., Deshpande, P., Cohen, B. N., Grady, S. R., Marks, M. J., Yohannes, D., Kenny, P. J., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00641 · Cited by 8 · see citing works

Elucidating the reinforcing effects of nicotine: a tribute to Nadia Chaudhri

Sved, A. F., Caggiula, A. R., & Donny, E. C. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06266-7 · Cited by 7 · see citing works

Cell‐Derived Vesicles for Single‐Molecule Imaging of Membrane Proteins

Moonschi, F. H., Effinger, A. K., Zhang, X., Martin, W. E., Fox-Loe, A. M., Heidary, D. K., DeRouchey, J. E., & Richards, C. I. (2014) · Angewandte Chemie · doi:10.1002/ange.201408707 · Cited by 6 · see citing works

Nicotine Administration Augments Abdominal Aortic Aneurysm Progression in Rats

Hadzikadunic, H., Sjælland, T. B., Lindholt, J. S., Steffensen, L. B., Beck, H. C., Kavaliūnaitė, E., Rasmussen, L. M., & Stubbe, J. (2023) · Biomedicines · doi:10.3390/biomedicines11051417 · Cited by 5 · see citing works

A method for bidirectional solution exchange—“Liquid bullet” applications of acetylcholine to α7 nicotinic receptors

Fedorov, N. B., Benson, L., Graef, J. D., Hyman, J., Sollenberger, J., Pettersson, F., Lippiello, P. M., & Bencherif, M. (2012) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2012.02.005 · Cited by 5 · see citing works

Synthesis, Nicotinic Acetylcholine Binding, and in Vitro and in Vivo Pharmacological Properties of 2′-Fluoro-(carbamoylpyridinyl)deschloroepibatidine Analogues

Ondachi, P. W., Castro, A. H., Luetje, C. W., Wageman, C. R., Marks, M. J., Damaj, M. I., Mascarella, S. W., Navarro, H. A., & Carroll, F. I. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00107 · Cited by 5 · see citing works

α6 nicotinic acetylcholine receptors: A pharmacological challenge with untapped therapeutic promise

Zhang, B., Mao, K., Ma, L., Chen, Y.-S., Ren, M., Xiong, Y., Zhangsun, D., Dong, S., Luo, S., & Gao, B. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118300 · Cited by 3 · see citing works

Flow-cell radionuclide analysis

L’Annunziata, M. F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814395-7.00010-6 · Cited by 3 · see citing works

Competition, Selectivity and Efficacy of Analogs of A-84543 for Nicotinic Acetylcholine Receptors with Repositioning of Pyridine Nitrogen

Ogunjirin, A. E., Fortunak, J., Brown, L. L., Xiao, Y., & Dávila‐García, M. I. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1705-z · Cited by 3 · see citing works

Flow-Cell Analysis

L’Annunziata, M. F. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384873-4.00017-7 · Cited by 3 · see citing works

Attenuated nicotine‐like effects of varenicline but not other nicotinic ACh receptor agonists in monkeys receiving nicotine daily

Cunningham, C. S., Moerke, M. J., Javors, M. A., Carroll, F. I., & McMahon, L. R. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13635 · Cited by 2 · see citing works

Differential cross-tolerance to the effects of nicotinic acetylcholine receptor drugs in C57BL/6J mice following chronic varenicline

de Moura, F. B., & McMahon, L. R. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000452 · Cited by 3 · see citing works

Nicotine Self-Administration as Paradigm for Medication Discovery for Smoking Cessation: Recent Findings in Medications Targeting the Cholinergic System

Trigo, J. M., & Foll, B. L. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9554-7_11 · Cited by 3 · see citing works

Development of a novel alcohol and nicotine concurrent access (ANCA) self-administration procedure in baboons

Holtyn, A. F., Davis, C. M., & Weerts, E. M. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107665 · Cited by 2 · see citing works

Enhancement of Opioid Antinociception by Nicotinic Ligands

de Moura, F. B., & Bergman, J. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000423 · Cited by 2 · see citing works

The discriminative stimulus effects of epibatidine in C57BL/6J mice

de Moura, F. B., Hiranita, T., & McMahon, L. R. (2020) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000555 · Cited by 1 · see citing works

Nicotine treatment shows the therapeutic effect for imiquimod-induced psoriasiform dermatitis in alpha 7- nicotinic acetylcholine receptor-independent manner

Murayama, M. A. (2022) · Translational and Regulatory Sciences · doi:10.33611/trs.2021-028 · Cited by 1 · see citing works

Contribution of Variants in CHRNB3/A6 Gene Cluster on Chromosome 8 to Smoking Dependence

Li, M. D. (2018) · Springer eBooks · doi:10.1007/978-981-10-7530-8_6 · Cited by 1 · see citing works

A quantitative analysis of the value-enhancing effects of nicotine, bupropion, and varenicline in male and female rats

Barrett, S. T. (2014) · Lincoln (University of Nebraska)

Role of the Ventral Tegmental Area and Ventral Tegmental Area Nicotinic Acetylcholine Receptors in the Incentive Amplifying Effect of Nicotine

Sheppard, A. B. (2014) · Digital Commons - East Tennessee State University (East Tennessee State University)

Nicotinic Acetylcholine Receptors in Alzheimer’s and Parkinson’s Disease

Dineley, K. T. (2014) · The Receptors · doi:10.1007/978-1-4939-1167-7_19

Critical Role for Brain Stress Systems in the Negative Affective State Associated With Nicotine Withdrawal

Qi, X., Bruijnzeel, D. M., & Bruijnzeel, A. W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802574-1.00010-7

The Effects of Binge-Like Sucrose Consumption on the Mesolimbic Reward Pathway in the Brain

Shariff, M. R. (2017) · Queensland University of Technology · doi:10.5204/thesis.eprints.107900

Investigating the Role of Neuronal Nicotinic Acetylcholine Receptor Subtypes in the Acquisition and Maintenance of Alcohol Use Disorders

Tarren, J. R. (2018) · Queensland University of Technology · doi:10.5204/thesis.eprints.118142

Does Pre-cessation Physical Activity Impact Smoking Treatment Outcomes? A Longitudinal Study of Treatment-seeking Smokers in the General Population

Hoang, M. (2020) · TSpace (University of Toronto)

Caracterización molecular de una serie de análogos de nicotina y su interacción con receptores nicotínicos α7

Cruz, G. P. B. (2020) · doi:10.11144/javeriana.10554.34028

BindingDB Entry 50034102: Unichiral 2-(2'-pyrrolidinyl)-1,4-benzodioxanes: the 2R,2'S diastereomer of the N-methyl-7-hydroxy analogue is a potenta4ß2- anda6ß2-nicotinic acetylcholine receptor partial agonist.

BindingDB (2012) · UC San Diego · doi:10.7270/q2k64jgc

BindingDB Entry 50041962: Structure-activity relationship studies of sulfonylpiperazine analogues as novel negative allosteric modulators of human neuronal nicotinic receptors.

BindingDB (2013) · UC San Diego · doi:10.7270/q2057h6w

Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation

Mohamed, T. S., Jayakar, S. S., & Hamouda, A. K. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00071 · Cited by 27 · see citing works

High-Throughput Patch Clamp Screening in Human α6-Containing Nicotinic Acetylcholine Receptors

Armstrong, L. C., Kirsch, G. E., Fedorov, N. B., Wu, C., Kuryshev, Y. A., Sewell, A. L., Liu, Z., Motter, A. L., Leggett, C. S., & Orr, M. S. (2017) · SLAS DISCOVERY · doi:10.1177/2472555217696794 · Cited by 8 · see citing works

Searching for structural determinants of agonist selectivity in nicotinic acetylcholine receptors

Minguez, T. (2020) · Radar (Oxford Brookes University) · doi:10.24384/mr2z-2y22

Roles of nicotinic acetylcholine receptor β subunits in function of human α4‐containing nicotinic receptors

Wu, J., Liu, Q., Yu, K., Hu, J., Kuo, Y., Segerberg, M., John, P. A. S., & Lukas, R. J. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.114645 · Cited by 73 · see citing works

Targeting the α4β2- and α7-Subtypes of Nicotinic Acetylcholine Receptors for Smoking Cessation Medication Development.

Nair, L. R., & Liu, X. (2019) · PubMed · Cited by 10 · see citing works